PETALING JAYA: Malaysia has thanked the United States for donating one million doses of the Pfizer-BioNTech ... the arrival of the vaccine contribution from the US. Cancel anytime.

GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District ...

Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and better-than-expected demand for its COVID ...

Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...

GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and ...

The company said it would submit the information to the US Food and Drug Administration for potential expansion of the vaccine’s availability to people ages 18 to 59. Pfizer’s RSV vaccine ...

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...

Covid-19 jab rivals face off in court today as a weeks-long trial begins over an infringement on the life-saving vaccine technology's patent. Pharmaceutical giant Pfizer and drug manufacturer ...

Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines ...

A late-stage trial of Pfizer’s RSV vaccine showed promising results in adults under 60 years old, suggesting the shot could help people as young as 18, the company announced Tuesday, amid an ...

The lawsuit adds to a web of high-stakes US court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their vaccines, including a case brought by Moderna against ...